News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Walk News

Click on a headline to read the latest about Parkinson's Unity Walk. 

Parkinson's Unity Walk Elects New Board Member; Announces New Roles for Two Board Members

The Parkinson's Unity Walk mourns the loss of Lupe McCann

2018 Light of Day Winterfest Will Kick Off Fundraising in NJ

The 23rd Parkinsonís Unity Walk Raised Over $1.5 Million in Donations for Parkinsonís Disease Research

Top 50 Teams - Parkinson's Unity Walk 2017

Submit Your Favorite Walk Moments from the 2017 Parkinson's Unity Walk

The 23rd Parkinsonís Unity Walk to Take Place on Saturday, April 22nd in New York Cityís Central Park

Letter on Health Care Reform to President-Elect Trump from Patient Advocacy Organizations

Your Dollars at Work Ė 2016 PUW Research Grants Have Been Awarded

2016 PUW Memory Quilt is Awarded to Rockiní Roses

The 22nd Parkinsonís Unity Walk Raised More Than $1.4 Million for Parkinsonís Research

Top 50 Teams - Parkinson's Unity Walk 2016

Muhammad Ali, Truly the "Greatest"

Favorite Walk Moments from the 2016 Parkinson's Unity Walk

Team Photos from the 22nd Parkinson's Unity Walk

Submit Your Favorite Walk Moments from the 22nd Unity Walk

Attendees at the 22nd Parkinsonís Unity Walk Will Find Valuable New Resources for Managing Symptoms of Parkinsonís Disease

The 22nd Parkinsonís Unity Walk to Take Place on Saturday, April 23rd in New York Cityís Central Park

Winner of Register Early Incentive Announced

Rock Steady Boxing is the Recipient of the 2016 Alan Bonander Humanitarian Award

Register Early for a Chance to Win a Visa Gift Card

back to top

Sponsor & Foundation News

Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced PD

Voyagerís AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinsonís Disease

GOCOVRI for Dyskinesia Gets Orphan Drug Designation

Distinguished Movement Disorders Researchers to Lead Fresco Institute at NYU Langone Health

New Phase 3 Trial to Test Nuplazid for Parkinsonís Psychosis in Array of Dementia Patients

Voyager Therapeutics Presents Promising Parkinsonís Data

Adamas Announces FDA Approval of GOCOVRIô as First and Only Medication for the Treatment of Dyskinesia in Parkinsonís Disease Patients

The Michael J. Fox Foundation Announces Award to Drive Phase IIa Clinical Trial Investigating Potential Safety and Benefit of Nilotinib in PD

Forbes Includes Acadia, Maker of Nuplazid on List of Most Innovative Growth Companies

Mitsubishi Buys Israel's NeuroDerm for $1.1B

Participants Invited to Take Survey on Vision and Parkinsonís Disease

US WorldMeds is Now Distributing XADAGO® (Safinamide) in the U.S. for PD Patients

Acorda Submits New Drug Application to U.S. Food and Drug Administration for CVT-301

Adamas Presents Expanded Analysis from the ADS-5102 Open-Label Study

NeuroDerm Presents Six Posters at the 21st International Congress of Parkinsonís Disease and Movement Disorders

Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinsonís Patients

Survey Examines Social Support in Parkinsonís Disease from the Patientís Perspective

UCB Adds Website for its Facebook-based Parkinson's Community

Acorda Expands Alexa Skill Offering for Parkinsonís Awareness Month

Acorda Announces Long-Term Safety Data for CVT-301

FDA Approves Xadago to Treat Parkinsonís Disease

US WorldMeds is Funding Clinical Trial Studying Effectiveness of New Infusion Therapy to Help Smooth Out Movement for Patients with PD

Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301

LSVT BIG Seminar on Sunday, February 5, 2017 in West Orange, NJ

The Parkinsonís Institute and Clinical Center Awarded $1.9 Million from California Institute for Regenerative Medicine

back to top

News in the Parkinson's Disease Community

Veteransí Coverage of Agent Orange-Related Diseases Delayed

OHSU Study Validates Deep Brain Surgery While Asleep for Parkinson's Patients

Insightec Gets FDA Blessing for Study of Exablate Neuro to Treat Parkinsonís Involuntary Movements

New UMass Lowell Study to Explore Link Between Gut Bacteria and Parkinson's Disease

Deep Sleep Linked to Cognitive Performance in People Living with Parkinson's

First Patient Treated with Titan Pharmaceuticals' Subdermal Implant for Parkinson's Disease

Scientists Identify the Structure of a Key Enzyme that Protects the Brain Against PD

Researchers Develop New Tool to Diagnose First Signs of Parkinson's Disease

MSU Researcher Hopes to Link Sense of Smell with Development of PD

Asthma Medication May Reduce the Risk of Developing Parkinsonís Disease

Telemedicine as Effective as In-person Care for Parkinson's Disease

Global Kinetics Corp Secures First US Patent for its Digital Health System

PD Movement Labís ďPD OutliersĒ Podcast with John Ball

LSVT Global Offers Free Educational Seminar for People with Parkinsonís Disease

Diabetes Drug Shows Promise Against Parkinsonís Disease

Drug Discovery: Alzheimer's and Parkinson's Spurred by Same Enzyme

Global Kinetics Launching Large Randomized Study of Wearable for Parkinsonís Disease

Study Suggests CLR01 May Improve Symptoms of Early Parkinsonís

Statins May Speed Symptoms of Onset Parkinson's Disease in Some People

Autoimmunity May Have Role in Parkinson's Disease

Balance and Movement Improved in Animal Model of Parkinsonís Disease

Low-fat Dairy Intake May Raise Parkinson's Risk

Tom Isaacs, President of The Cure Parkinson's Trust Has Died

Biomarkers for Cognitive Impairment in Parkinson's Disease Revealed

New App Adjusts Brain Stimulators For Parkinsonís Patients

Microsoft's 'Project Emma' is a Wearable for People Living with PD

NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinsonís Unity Walk

back to top